These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8817157)

  • 1. Elevated plasma adrenomedullin level in hyperthyroidism.
    Taniyama M; Kitamura K; Ban Y; Eto T; Katagiri T
    Eur J Clin Invest; 1996 Jun; 26(6):454-6. PubMed ID: 8817157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of circulating proadrenomedullin-N terminal 20-peptide in thyrotoxicosis.
    Taniyama M; Kitamura K; Ban Y; Sugita E; Ito K; Katagiri T
    Clin Endocrinol (Oxf); 1997 Mar; 46(3):271-4. PubMed ID: 9156034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients.
    Diekman MJ; Harms MP; Endert E; Wieling W; Wiersinga WM
    Eur J Endocrinol; 2001 Apr; 144(4):339-46. PubMed ID: 11275942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased plasma levels of adrenomedullin in patients with heart failure.
    Nishikimi T; Saito Y; Kitamura K; Ishimitsu T; Eto T; Kangawa K; Matsuo H; Omae T; Matsuoka H
    J Am Coll Cardiol; 1995 Nov; 26(6):1424-31. PubMed ID: 7594065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cytokines levels in Graves' disease.
    Al-Humaidi MA
    Saudi Med J; 2000 Jul; 21(7):639-44. PubMed ID: 11500727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
    Izumi Y; Hidaka Y; Tada H; Takano T; Kashiwai T; Tatsumi KI; Ichihara K; Amino N
    Clin Endocrinol (Oxf); 2002 Jul; 57(1):51-8. PubMed ID: 12100069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of increased plasma adrenomedullin concentration in patients with cirrhosis.
    Kojima H; Tsujimoto T; Uemura M; Takaya A; Okamoto S; Ueda S; Nishio K; Miyamoto S; Kubo A; Minamino N; Kangawa K; Matsuo H; Fukui H
    J Hepatol; 1998 May; 28(5):840-6. PubMed ID: 9625320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hunger-satiety signals in patients with Graves' thyrotoxicosis before, during, and after long-term pharmacological treatment.
    Röjdmark S; Calissendorff J; Danielsson O; Brismar K
    Endocrine; 2005 Jun; 27(1):55-61. PubMed ID: 16077172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective cohort study: do patients with graves' disease need to be euthyroid prior to surgery?
    Al Jassim A; Wallace T; Bouhabel S; Majdan A; Hier M; Forest VI; Payne R
    J Otolaryngol Head Neck Surg; 2018 May; 47(1):37. PubMed ID: 29784035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma adrenomedullin concentration patients with Graves' disease.
    Nakamura S; Isaji M; Ishimori M
    Intern Med; 2004 Jul; 43(7):628-9. PubMed ID: 15335196
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: a pharmacokinetic study.
    Meeran K; O'Shea D; Upton PD; Small CJ; Ghatei MA; Byfield PH; Bloom SR
    J Clin Endocrinol Metab; 1997 Jan; 82(1):95-100. PubMed ID: 8989240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An elevation of stem cell factor in patients with hyperthyroid Graves' disease.
    Yamada T; Sato A; Aizawa T; Ootsuka H; Miyahara Y; Sakai H; Terao A; Onuma S; Ito Y; Kanamori A; Nakamura Y; Tejima E
    Thyroid; 1998 Jun; 8(6):499-504. PubMed ID: 9669287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders.
    Cheung B; Leung R
    Clin Sci (Lond); 1997 Jan; 92(1):59-62. PubMed ID: 9038592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of plasma free thyroxine levels with insulin sensitivity and metabolic clearance rate of insulin in patients with hyperthyroid Graves' disease.
    Ohguni S; Notsu K; Kato Y
    Intern Med; 1995 May; 34(5):339-41. PubMed ID: 7647398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term adrenomedullin administration in experimental heart failure.
    Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM
    Hypertension; 2002 Nov; 40(5):667-72. PubMed ID: 12411460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.
    Burch HB; Solomon BL; Cooper DS; Ferguson P; Walpert N; Howard R
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3016-21. PubMed ID: 11443161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.
    Nicoloff JT; Low JC; Dussault JH; Fisher DA
    J Clin Invest; 1972 Mar; 51(3):473-83. PubMed ID: 4110897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactivity and interactions of adrenomedullin and brain natriuretic peptide in patients with heart failure.
    Lainchbury JG; Nicholls MG; Espiner EA; Yandle TG; Lewis LK; Richards AM
    Hypertension; 1999 Jul; 34(1):70-5. PubMed ID: 10406826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.